MQ Lacy

671 total citations
11 papers, 517 citations indexed

About

MQ Lacy is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, MQ Lacy has authored 11 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in MQ Lacy's work include Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cancer Treatment and Pharmacology (3 papers). MQ Lacy is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cancer Treatment and Pharmacology (3 papers). MQ Lacy collaborates with scholars based in United States. MQ Lacy's co-authors include Angela Dispenzieri, MA Gertz, PR Greipp, TE Witzig, MR Litzow, Rafaël Fonseca, S. Vincent Rajkumar, RA Kyle, DJ Inwards and Susan M. Geyer and has published in prestigious journals such as Leukemia and Bone Marrow Transplantation.

In The Last Decade

MQ Lacy

11 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MQ Lacy United States 11 408 347 229 81 37 11 517
MA Gertz United States 7 413 1.0× 268 0.8× 204 0.9× 82 1.0× 50 1.4× 7 499
Irini Xilouri Greece 7 208 0.5× 238 0.7× 123 0.5× 119 1.5× 37 1.0× 13 375
Anna Tasidou Greece 9 187 0.5× 233 0.7× 106 0.5× 102 1.3× 34 0.9× 13 375
Ioannis Panagiotidis Greece 10 242 0.6× 255 0.7× 155 0.7× 64 0.8× 21 0.6× 22 392
Stephen R. Zeldenrust United States 10 302 0.7× 417 1.2× 152 0.7× 201 2.5× 55 1.5× 16 573
Cesare Bergonzi Italy 9 229 0.6× 175 0.5× 124 0.5× 40 0.5× 11 0.3× 19 318
M Masi Italy 13 458 1.1× 218 0.6× 129 0.6× 105 1.3× 12 0.3× 26 597
Morten Salomo Denmark 10 245 0.6× 195 0.6× 170 0.7× 55 0.7× 11 0.3× 29 344
Danai Dima United States 12 180 0.4× 170 0.5× 233 1.0× 40 0.5× 24 0.6× 69 409
Ali Tabarroki United States 10 448 1.1× 348 1.0× 60 0.3× 225 2.8× 61 1.6× 27 679

Countries citing papers authored by MQ Lacy

Since Specialization
Citations

This map shows the geographic impact of MQ Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MQ Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MQ Lacy more than expected).

Fields of papers citing papers by MQ Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MQ Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MQ Lacy. The network helps show where MQ Lacy may publish in the future.

Co-authorship network of co-authors of MQ Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of MQ Lacy. A scholar is included among the top collaborators of MQ Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MQ Lacy. MQ Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Kumar, Shaji, et al.. (2001). High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transplantation. 28(4). 381–385. 27 indexed citations
3.
Inwards, DJ, et al.. (2001). Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation. Bone Marrow Transplantation. 28(7). 673–680. 37 indexed citations
4.
Rajkumar, S. Vincent, Angela Dispenzieri, Rafaël Fonseca, et al.. (2001). Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia. 15(8). 1274–1276. 134 indexed citations
5.
Gertz, MA, MQ Lacy, DJ Inwards, et al.. (2000). Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma. Bone Marrow Transplantation. 26(1). 45–50. 30 indexed citations
6.
Rajkumar, S. Vincent, Rafaël Fonseca, Angela Dispenzieri, et al.. (2000). Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplantation. 26(9). 979–983. 50 indexed citations
7.
Gertz, MA, MQ Lacy, & Angela Dispenzieri. (2000). Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report. Bone Marrow Transplantation. 25(5). 465–470. 60 indexed citations
8.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplantation. 24(5). 497–503. 40 indexed citations
9.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. Bone Marrow Transplantation. 23(12). 1261–1266. 29 indexed citations
10.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplantation. 23(12). 1267–1272. 51 indexed citations
11.
Lacy, MQ, DJ Inwards, PR Greipp, et al.. (1999). Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma. Bone Marrow Transplantation. 23(3). 221–226. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MA Gertz Breakdown of academic impact, for papers by Irini Xilouri Breakdown of academic impact, for papers by Anna Tasidou Breakdown of academic impact, for papers by Ioannis Panagiotidis Breakdown of academic impact, for papers by Stephen R. Zeldenrust Breakdown of academic impact, for papers by Cesare Bergonzi Breakdown of academic impact, for papers by M Masi Breakdown of academic impact, for papers by Morten Salomo Breakdown of academic impact, for papers by Danai Dima Breakdown of academic impact, for papers by Ali Tabarroki
Rankless by CCL
2026